Muscle multiorgan crosstalk with MG53 as a myokine for tissue repair and regeneration
- PMID: 34052525
- PMCID: PMC8513491
- DOI: 10.1016/j.coph.2021.04.005
Muscle multiorgan crosstalk with MG53 as a myokine for tissue repair and regeneration
Abstract
Through stress and injury to tissues, the cell membrane is damaged and can lead to cell death and a cascade of inflammatory events. Soluble factors that mitigate and repair membrane injury are important to normal homeostasis and are a potential therapeutic intervention for regenerative medicine. A myokine is a type of naturally occurring factors that come from muscle and have impact on remote organs. MG53, a tripartite motif-containing family protein, is such a myokine which has protective effects on lungs, kidneys, liver, heart, eye, and brain. Three mechanisms of action for the beneficial regenerative medicine potential of MG53 have been identified and consist of 1) repair of acute injury to the cellular membrane, 2) anti-inflammatory effects associated with chronic injuries, and 3) rejuvenation of stem cells for tissue regeneration. As such, MG53 has the potential to be a novel and effective regeneration medicine therapeutic.
Keywords: Cell membrane repair; MG53; Myokine; Regenerative medicine; TRIM protein.
Copyright © 2021 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Conflict of interest statement JM and TT hold equity interest in TRIM-edicine, Inc., a university spin-off biotechnology company that develops MG53 for regenerative medicine application. Patents on the use of MG53 are held by Rutgers University and The Ohio State University.
Figures
Similar articles
-
Sustained elevation of MG53 in the bloodstream increases tissue regenerative capacity without compromising metabolic function.Nat Commun. 2019 Oct 11;10(1):4659. doi: 10.1038/s41467-019-12483-0. Nat Commun. 2019. PMID: 31604915 Free PMC article.
-
Zinc Binding to MG53 Protein Facilitates Repair of Injury to Cell Membranes.J Biol Chem. 2015 May 29;290(22):13830-9. doi: 10.1074/jbc.M114.620690. Epub 2015 Apr 13. J Biol Chem. 2015. PMID: 25869134 Free PMC article.
-
Recombinant MG53 protein modulates therapeutic cell membrane repair in treatment of muscular dystrophy.Sci Transl Med. 2012 Jun 20;4(139):139ra85. doi: 10.1126/scitranslmed.3003921. Sci Transl Med. 2012. PMID: 22723464 Free PMC article.
-
MG53, A Tissue Repair Protein with Broad Applications in Regenerative Medicine.Cells. 2021 Jan 11;10(1):122. doi: 10.3390/cells10010122. Cells. 2021. PMID: 33440658 Free PMC article. Review.
-
MG53: A potential therapeutic target for kidney disease.Pharmacol Res Perspect. 2023 Feb;11(1):e01049. doi: 10.1002/prp2.1049. Pharmacol Res Perspect. 2023. PMID: 36583464 Free PMC article. Review.
Cited by
-
Structural basis for TRIM72 oligomerization during membrane damage repair.Nat Commun. 2023 Mar 21;14(1):1555. doi: 10.1038/s41467-023-37198-1. Nat Commun. 2023. PMID: 36944613 Free PMC article.
-
TRIM72 Alleviates Muscle Inflammation in mdx Mice via Promoting Mitophagy-Mediated NLRP3 Inflammasome Inactivation.Oxid Med Cell Longev. 2023 Jan 18;2023:8408574. doi: 10.1155/2023/8408574. eCollection 2023. Oxid Med Cell Longev. 2023. PMID: 36713032 Free PMC article.
-
The molecular athlete: exercise physiology from mechanisms to medals.Physiol Rev. 2023 Jul 1;103(3):1693-1787. doi: 10.1152/physrev.00017.2022. Epub 2023 Jan 5. Physiol Rev. 2023. PMID: 36603158 Free PMC article. Review.
-
Myokines: Novel therapeutic targets for diabetic nephropathy.Front Endocrinol (Lausanne). 2022 Oct 25;13:1014581. doi: 10.3389/fendo.2022.1014581. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36387916 Free PMC article. Review.
-
Resealing and rebuilding injured muscle.Science. 2021 Oct 15;374(6565):262-263. doi: 10.1126/science.abm2240. Epub 2021 Oct 14. Science. 2021. PMID: 34648349 Free PMC article.
References
-
- Petersen AM, Pedersen BK: The anti-inflammatory effect of exercise. J Appl Physiol 2005, 98:1154–1162. - PubMed
-
- Gorgens SW, Eckardt K, Jensen J, Drevon CA, Eckel J: Exercise and regulation of adipokine and myokine production. Prog Mol Biol Transl Sci 2015, 135:313–336. - PubMed
-
- Pillon NJ, Bilan PJ, Fink LN, Klip A: Cross-talk between skeletal muscle and immune cells: muscle-derived mediators and metabolic implications. Am J Physiol Endocrinol Metab 2013, 304:E453–E465. - PubMed
-
- Cai C, Masumiya H, Weisleder N, Matsuda N, Nishi M, Hwang M, Ko JK, Lin P, Thornton A, Zhao X, Pan Z, Komazaki S, Brotto M, Takeshima H, Ma J: MG53 nucleates assembly of cell membrane repair machinery. Nat Cell Biol 2009, 11:56–64. - PMC - PubMed
-
This is a milestone study that describes the cell memebrane repair function of MG53.
-
- McNeil P: Membrane repair redux: redox of MG53. Nat Cell Biol 2009, 11:7–9. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
